Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics

New article by Fundacion MEDINA in collaboration with the Department of Oncology at the Ludwig Institute for Cancer Research of the University of Lausanne, the Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM) of the University of Granada, the Service of Medical Oncology at the Virgen de las Nieves University Hospital & the Biosanitary Institute of Granada:
“Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics”

Abstract